From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more Podcast Por capa

From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more

From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more

Ouça grátis

Ver detalhes do programa

Sobre este título

 Special edition of the JAMA Editor's Summary featuring the JAMA Network articles published at the 2025 European Society of Cardiology Congress. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, with JAMA Executive Editor Gregory Curfman, MD, JAMA Senior Editor Philip Greenland, MD, and JAMA Cardiology Editor Robert O. Bonow, MD, MS. Related Content: Remote Screening for Asymptomatic Atrial FibrillationLong-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial FibrillationSystolic Blood Pressure and Microaxial Flow Pump–Associated Survival in Infarct-Related Cardiogenic ShockHelicobacter pylori Screening After Acute Myocardial InfarctionPhysiology-Guided Complete Revascularization in Older Patients With Myocardial InfarctionFractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel DiseaseTranscatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate RiskSemaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionBivalent RSV Prefusion F Protein–Based Vaccine for Preventing Cardiovascular Hospitalizations in Older AdultsHigh-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older AdultsRisk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza VaccineClonal Hematopoiesis and Risk of New-Onset Myocarditis and PericarditisParticipation of Women in Cardiovascular Trials From 2017 to 2023Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region
Ainda não há avaliações